Shared Decision Making in Graves Disease - Graves Disease (GD) Choice

Sponsor
Mayo Clinic (Other)
Overall Status
Completed
CT.gov ID
NCT02107794
Collaborator
(none)
93
1
2
28
3.3

Study Details

Study Description

Brief Summary

The investigators' decision aid for patients with GD, GD Choice, will be the result of a user-centered participatory action research involving) synthesis of the best available evidence from the literature and real-world registry experience, ii) input and involvement of patients, clinicians and other stakeholders, iii) direct observation of encounters and iv) extensive field-testing. The goal is to create a decision aid that will be rigorously evidence-based, clear and complete, able to be used by clinicians with minimal training time, while satisfying extant standards for rigorous high-quality shared decision making tools.

Condition or Disease Intervention/Treatment Phase
  • Other: Decision Aid
N/A

Study Design

Study Type:
Interventional
Actual Enrollment :
93 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Official Title:
Shared Decision Making in Graves Disease - Graves Disease (GD) Choice
Study Start Date :
Dec 1, 2012
Actual Primary Completion Date :
Apr 1, 2015
Actual Study Completion Date :
Apr 1, 2015

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Decision Aid

Observation of clinical encounter using the decision aid, via video, audio or written notes.

Other: Decision Aid
Paper based decision aid will be utilized to facilitate treatment option conversation between clinician and patient.
Other Names:
  • DA
  • No Intervention: Usual Care

    Observations in clinical encounters, either video, audio, or observational notes.

    Outcome Measures

    Primary Outcome Measures

    1. Decisional Quality (Knowledge, Decisional Conflict, Satisfaction) of 100 participants [up to 2 weeks post-visit]

      Outcome measure to be assessed through post-visit surveys.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • Adults ≥ 18 years

    • Diagnosis of Graves Disease

    • Appointment with endocrinologist to discuss treatment options for Graves Disease

    Exclusion Criteria:
    • Major barriers to participate in shared decision making or to providing informed consent (i.e. dementia, severe hearing or visual impairment)

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Mayo Clinic Rochester Minnesota United States 55905

    Sponsors and Collaborators

    • Mayo Clinic

    Investigators

    • Principal Investigator: Victor M Montori, M.D., Mayo Clinic

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Victor Montori, M.D., Mayo Clinic
    ClinicalTrials.gov Identifier:
    NCT02107794
    Other Study ID Numbers:
    • 12-007708
    First Posted:
    Apr 8, 2014
    Last Update Posted:
    Apr 7, 2015
    Last Verified:
    Apr 1, 2015

    Study Results

    No Results Posted as of Apr 7, 2015